Bank of America’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $873 | Buy |
982
+6
| +0.6% | +$5 | ﹤0.01% | 6521 |
|
2025
Q1 | $507 | Buy |
976
+1
| +0.1% | +$1 | ﹤0.01% | 6461 |
|
2024
Q4 | $497 | Sell |
975
-41
| -4% | -$21 | ﹤0.01% | 6485 |
|
2024
Q3 | $3.6K | Buy |
1,016
+42
| +4% | +$149 | ﹤0.01% | 6136 |
|
2024
Q2 | $7.7K | Sell |
974
-1,623
| -62% | -$12.8K | ﹤0.01% | 6053 |
|
2024
Q1 | $35.2K | Buy |
2,597
+2,592
| +51,840% | +$35.1K | ﹤0.01% | 5738 |
|
2023
Q4 | $58 | Buy |
+5
| New | +$58 | ﹤0.01% | 6510 |
|
2023
Q2 | – | Hold |
0
| – | -$3 | – | 6868 |
|
2023
Q1 | – | Sell |
-19
| Closed | -$466 | – | 6866 |
|
2022
Q4 | $466 | Sell |
19
-14
| -42% | -$343 | ﹤0.01% | 6615 |
|
2022
Q3 | $1K | Sell |
33
-40
| -55% | -$1.21K | ﹤0.01% | 6799 |
|
2022
Q2 | $3K | Hold |
73
| – | – | ﹤0.01% | 6875 |
|
2022
Q1 | $3K | Sell |
73
-2,854
| -98% | -$117K | ﹤0.01% | 7158 |
|
2021
Q4 | $148K | Buy |
2,927
+2,891
| +8,031% | +$146K | ﹤0.01% | 5852 |
|
2021
Q3 | $2K | Buy |
36
+34
| +1,700% | +$1.89K | ﹤0.01% | 6978 |
|
2021
Q2 | $0 | Sell |
2
-9
| -82% | – | ﹤0.01% | 7051 |
|
2021
Q1 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 6606 |
|
2020
Q2 | – | Sell |
-824
| Closed | -$25K | – | 6309 |
|
2020
Q1 | $25K | Buy |
+824
| New | +$25K | ﹤0.01% | 5496 |
|
2019
Q2 | – | Sell |
-622
| Closed | -$34K | – | 6437 |
|
2019
Q1 | $34K | Buy |
+622
| New | +$34K | ﹤0.01% | 5573 |
|
2018
Q4 | – | Sell |
-20
| Closed | -$1K | – | 6421 |
|
2018
Q3 | $1K | Sell |
20
-984
| -98% | -$49.2K | ﹤0.01% | 6371 |
|
2018
Q2 | $22K | Buy |
1,004
+904
| +904% | +$19.8K | ﹤0.01% | 5740 |
|
2018
Q1 | $4K | Sell |
100
-53
| -35% | -$2.12K | ﹤0.01% | 6049 |
|
2017
Q4 | $9K | Buy |
153
+99
| +183% | +$5.82K | ﹤0.01% | 5807 |
|
2017
Q3 | $3K | Buy |
+54
| New | +$3K | ﹤0.01% | 5998 |
|